Stay updated on SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:15:48.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added 'Squamous cell carcinoma of the head and neck' to the content and included a new Resources link to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-03-27T21:59:36.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision stamp updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-20T19:35:39.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-06T14:57:23.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.1 to v3.4.2. No user-facing content or functionality was altered.
    Difference
    0.0%
    Check dated 2026-02-12T15:45:55.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page shows a minor version bump from v3.4.0 to v3.4.1, a routine update with no visible changes to study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T11:21:12.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.